Review Article

Common Comorbidities in Patients with Remitting Seronegative and Symmetrical Synovitis with Pitting Edema (RS3PE)

Authors: Elmira Esmaeilzadeh, MD, Christopher R. Morris, MD

Abstract

Objectives: Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is considered a rare inflammatory rheumatologic disorder that is seen primarily in older adult men. Patients present with arthralgias of large joints accompanied by painful pitting edema of the hands and feet. Few studies have reported the prevalence of metabolic syndromes, including diabetes mellitus and hyperlipidemia in these patients.

Methods: This case series reviewed 25 patients who were diagnosed as having RS3PE in a private outpatient clinic.

Results: Nearly half of the patients (48%) had diabetes mellitus, predominantly type 2, and more than half of the patients (60%) had hyperlipidemia.

Conclusions: We believe that future case studies on RS3PE should include an assessment of various comorbidities that can be seen in patients with this autoinflammatory disorder. The increased availability of musculoskeletal ultrasound provides a potential area of study to differentiate this disorder from other inflammatory arthritis and improve reaching the correct diagnosis.
Posted in: Rheumatology and Orthopedics25

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Lakhmalla M, Dahiya DS, Kichloo A, et al. Remitting seronegative symmetrical synovitis with pitting edema: a review. J Investig Med 2021; 69:86–90.
 
2. Li H, Altman RD, Yao Q. RS3PE: clinical and research development. Curr Rheum Rep 2015;17:49.
 
3. Horai Y, Origuchi T, Iwanaga N, et al. Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome. Mod Rheumatol 2020;30:703–707.
 
4. Oyama K, Taniguchi JI, Goto R, et al. Remitting seronegative symmetrical synovitis with pitting edema syndrome in individuals with type 2 diabetes mellitus or impaired glucose tolerance. Diabetes Res Clin Pract 2015;110:e5–e8.
 
5. Sakoda H, Ito S, Kanda H, et al. Association between type 1 diabetes mellitus and remitting seronegative symmetrical synovitis with pitting edema: a case report. Diabetes Res Clin Pract 2011;91:e43–e44.
 
6. Joseph AD, Kumanan T, Aravinthan N, et al. An unusual case of remitting seronegative symmetrical synovitis with pitting edema: case report and literature review. SAGE Open Med Case Rep 2020;8:2050313x20910920.
 
7. Horai Y, Shimizu T, Okada A, et al. Dipeptidyl peptidase-4 inhibitor use is associated with a lower erythrocyte sedimentation rate in patients with remitting seronegative symmetrical synovitis with pitting oedema and preexisting diabetes mellitus. Mod Rheumatol 2022;32:830–833.
 
8. Law J, Nauka PC, Nguyen A, et al. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) associated with DPP-4 inhibitor. Am J Med 2021;134:e412–e414.
 
9. Olivieri I, Salvarani C, Cantini F. RS3PE syndrome: an overview. Clin Exp Rheumatol 2000;18:S53–S55.
 
10. Gisserot O, Crémades S, Landais C, et al. RS3PE revealing recurrent nonHodgkin's lymphoma. Joint Bone Spine 2004;71:424–426.
 
11. Beyne-Rauzy O, Revel V, Desfossez V, et al. RS3PE syndrome: an acute edematous polyarthritis of the elderly with variable prognosis. Ann Med Interne (Paris) 2001;152:276–278.
 
12. Kawashiri SY, Suzuki T, Okada A, et al. Differences in musculoskeletal ultrasound findings between RS3PE syndrome and elderly-onset rheumatoid arthritis. Clin Rheumatol 2020;39:1981–1988.
 
13. Horai Y, Honda M, Nishino A, et al. Anti-citrullinated protein antibody-positive rheumatoid arthritis associated with RS3PE syndrome-like symptoms and an elevated serum vascular endothelial growth factor level in a patient with myasthenia gravis. Intern Med 2014;53:895–898.
 
14. Lechleitner M, Hoppichler F, Kaser S. Autoimmune diseases in type 1 diabetes. Wien Klin Wochenschr 2016;128(Suppl 2):S201–S203.
 
15. Rehling T, Bjørkman AD, Andersen MB, et al. Diabetesis associated with musculoskeletal pain, osteoarthritis, osteoporosis, and rheumatoid arthritis. J Diabetes Res 2019;2019:6324348.
 
16. Nicolau J, Lequerré T, Bacquet H, et al. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 2017;84:411–416.
 
17. Cox ER, Coombes JS, Keating SE, et al. Not a painless condition: rheumatological and musculoskeletal symptoms in type 2 diabetes, and the implications for exercise participation. Curr Diabetes Rev 2020;16:211–219.
 
18. Yang YL, Chee W, Im EO. Type 2 diabetes and musculoskeletal symptoms among midlife women. Diabetes Educ 2019;45:520–528.
 
19. Dunn FL. Hyperlipidemia and diabetes. Med Clin North Am 1982;66: 1347–1360.
 
20. Zhou X, Zhang W, Liu X, et al. Interrelationship between diabetes and periodontitis: role of hyperlipidemia. Arch Oral Biol 2015;60:667–674.